|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
TrovaGene, Inc.
| | | Phone: | (858) 952-7570 | Year Established: | 1999 | Ticker: | TROV | Exchange: | NASDAQ | Main Contact: | George Samuel, JD, VP & General Counsel | | Other Contacts: | Thomas Adams, MD, Interim CEO & Chairman Mark Erlander, PhD, CSO Vicki Kelemen, VP, Corporate Communications
| | Company Description | TrovaGene (formerly Xenomics) is a clinical-stage, precision medicine oncology therapeutics company. Trovagene’s lead drug candidate, PCM-075, is a Polo-like Kinase 1 (PLK1) selective adenosine triphosphate (ATP) competitive inhibitor. | |
|
|
|
|
|